2025 Speakers

Pharma Thought Leaders

Annmarie Galli

, Head, Global Medical Affairs Research & Compassionate Use / Managed Access Programs

GSK

Antoine Robert

Post-Trial Access Global Lead

Sanofi

Ben Rotz

Associate Vice President - Global Medical Policy, Strategy, & Operations

Eli Lilly & Co.

Cassandra Slader

Global Head of Managed Access Programs

UCB

Catherine Singfield

Senior Director & Head of Medical, Evidence Optimisation and Managed Access Programmes Team

Jazz Pharmaceuticals

Katy Mulleady

Director, Pre-Approval Access Operations

Abbvie

Lisa Seifert

Distribution Expert - IMP Delivery

Boehringer Ingelheim

Maja Gallic

Head of Global Medical Affairs Operations & Excellence

Teva Pharmaceuticals

Martina Vanek

Manager for Special Programs

Boehringer Ingelheim

Nicola Gillott

Global Head of Expanded Access

Chiesi

Nina Heiss

Director Global Regulatory Affairs and Scientific Policy, PhD

Merck KGaA

Olga Andreeva

Global Medical Excellence Director

Novo Nordisk

Rachel Harrison

Director, Pre-Approval, Post-Trial Access Programmes, Medical Affairs & Evidence Generation

Argenx

Simon Morgan

Team Lead, Qualified Person

Pfizer

Zoe Zeliku

Associate Director, Clinical Development, Value Evidence, Outcomes & Oncology

GSK

Biotech Thought Leaders

Bethany Bearden, Blueprint Bio, 3rd Operationalise: Early Access Programmes Europe 2024

Bethany Bearden

Associate Director, Early Access Programmes Operations

Blueprint Medicines

Chiara Troncatti

Head of Business Operations, EMEA

Avidity Biosciences

Dorian Readnour

Executive Director - global patient access

Sarepta Therapeutics

Kjersten Teeter

Director, Head, Medical Affairs

Blueprint Medicines

Magali Taiel

Chief Medical Officer

GenSight Biologics

Mallory Fredericks

Associate Director - Global Patient Access

SpringWorks Therapeutics

Michela Pantaleoni

Chief Market Access Officer

Napo Therapeutics

Natalia Kashtalian

Medical Excellence Manager

Sobi

Sara Tagliatatela

Senior Director, Global Quality Systems & Compliance

Kedrion Biopharma

Sarah Moore

Associate Director, Medical Affairs

ImmunoGen Switzerland GmbH (now a part of AbbVie)

Suzanne Webster

Director - International Patient Services & Global Access Post Clinical Trial

Sarepta Therapeutics

Tamara Popov

Global Medical Lead Nephrology

Vifor Pharma

Patient & Advocacy Voices

Chris Hendriksz

Chief Community Impact Officer

A Rare Cause

Harpreet Ram

President

GARDaccess

Tanya Collin-Histed

Chief Executive Officer

International Gaucher Alliance

Trusted Partners

Dennis Akkaya

Chief Commercial Officer

myTomorrows